butyryl)phosphatidylethanolamine) were explored. Standard experimental conditions were chosen and information on the relevant physicochemical parameters of the liposome dispersions was collected (mean particle diameter, size distribution, charge). The reproducibility of standard immunoliposomes prepared in subsequent batches in terms of Fab' binding, particle size and charge was established. In addition, preservation of immunoreactivity, no marker loss, and no aggregation/fusion was found for the standard immunoliposomes over a period o f at least 3 weeks at 4°C. In vitro up to 35000 immunoliposomes were estimated to bind per human ovarian carcinoma cell. Internalization of the immunoliposomes could not be demonstrated. Electron micrographs showed binding of specific immunoliposomes to human ovarian carcinoma cells growing intraperitoneally in athymic nude mice. K eywords: Liposome; Immunoliposome; Monoclonal antibody; Ovarian carcinoma; Targeted drug delivery; (Human) 0 0 0 5 -2 7 3 6 /9 5 /$ 0 9 .5 0 © 1995 Elsevier Science B.V. All rights reserved SSDI 0 0 0 5 -2 7 3 6 ( 9 4 ) 0 0 3 0 0 -9 U.K. Nässander et al./Biochimica et Biophysica Acta 1235 (1995) 126-139 127
Introduction
In principle, the conjugation of cell-specific antibodies to liposomes containing chemotherapeutic agents provides the possibility for selective drug delivery and cell type specific cytotoxicity [1] [2] [3] [4] . Indeed, such liposomes, re ferred to as immunoliposomes, have been shown to in crease cytotoxicity selectively in vitro in several murine tumor cell lines [5] [6] [7] [8] [9] [10] . Only a limited number of studies investigated the possibility to direct immunoliposomes to specific cells or tissues in vivo [11] [12] [13] [14] [15] [16] [17] [18] . From these studies the anatomical and physiological constraints interfering with successful site-specific delivery of drugs can be de rived. Maximum benefit of active targeting with immunoli posomes in vivo can be expected when the immunolipo-Corresponding author. Fax: + 3 1 30 517839. 1 UIPS is part of the research school Groningen Utrecht Institute for Drug Exploration (GUIDE). somes are injected into the compartment where the target tissue or cells are localized. Intraperitoneal (i.p.) administration of immunolipo somes containing tumoricidal agents has a strong phar macological and biological rationale for the treatment of ovarian cancer. Ovarian tumors usually spread over the serosal surfaces of the peritoneal cavity; dissemination via the blood circulation occurs later and less frequently. A major cause of death in ovarian cancer patients is the inability to control the disease within the peritoneal cavity. While the primary tumor and larger tumor nodules may be removed surgically, micronodular disease and floating tu mor colonies which are confined to the peritoneal cavity, cannot be treated adequately by surgery [19, 20] .
Immunoliposomes specifically directed against human ovarian carcinoma cells were prepared, characterized and tested for their binding capacity to human ovarian carci noma cells grown in vitro and in vivo. The effect of experimental variables on the liposome-cell interaction was quantified. These immunoliposomes were developed collected and concentrated. Finally, the concentrated pro tein solution was applied to a Superdex 200 pg (2 6 /6 0 ) column (Pharmacia) eluted with acetate buffer (100 mM NaAc, 88 mM NaCl, pH 7.4) in order to separate the F(ab')2 fragments from pepsin and residual amounts of Fc fragments and IgG. The F(ab')2 fragments were stored at -20° C prior to use.
Purity of IgG and F(ab')2 was assessed by sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE) under non-reducing conditions with a PhastSystem and Homogeneous 12.5 gels To determine the apparent molecular weights low weight stan dards (Bio-Rad Laboratories, Richmond, CA, USA) were used.
Isoelectric focusing (IEF) was performed with the same system using PhastGel IEF 3-9 gels (Pharmacia). The samples were routinely applied at the anodic side of the gel. The pH gradient over the gels was monitored with an IEF calibration kit (Pharmacia). Electrophoresis and silver staining were carried out according to manufacturer in structions.
The immunoreactivity was tested by flow cytometry. Cultured monolayers of OVCAR-4 cells (see below) were treated with trypsin/EDTA (0.25%/0.02%) and washed with Dulbecco's phosphate-buffered saline (DPBS, Gibco, Paisley, UK). OV-TL3 or RIV1000 (IgG or F(ab')2) anti bodies were diluted in DPBS containing 0.1% NaN3 as indicated. Cells (5 • 105) were incubated at 4° C for 45 min in 50 /xl antibody solution. After incubation, cells were washed twice with DPBS by centrifugation (5 min, 800 X g) and incubated at 4° C for 45 min with 50 /xl fluores cein-conjugated goat anti-(mouse IgG) (Capel Labs, Cooper Biomedical, Malvern, PA, USA) at a dilution of 1:80. The cells were washed twice and fixed with 200 /xl 0.1% paraformaldehyde and kept on ice until fluorescence was measured. The percentage of fluorescent cells is presented after subtraction of the percentage of fluorescent cells stained after incubation with only fluorescein-conjugate.
Fluorescence analysis was performed in a fluorescenceactivated cell sorter (Becton & Dickinson Immunocytometry
Mountain View, CA, USA). Analysis of the data was performed with Consort 30 software (Becton & Dickinson) on a Hewlett Packard 9920 S Computer. Data were calculated for 104 cells after gating the dot plots of the volume-sidescatter diagram.
Preparation of Fab1 fragments in 1 F(ab')2 fragments of OV-TL3 and RIV1000 (3 -4 mg)
-1.5 ml of acetate buffer (100 mM NaAc, 88 mM NaCl, pH 5.5), were routinely reduced with 20 mM DTT at pH 5.5 for 90 min at room temperature under nitrogen atmosphere [22] . DTT was removed by gel chromatog raphy on a Sephadex G-25M column (PD-10, Pharmacia). Pre-equilibration and elution occurred with deoxygenated acetate buffer (100 mM NaAc. 88 mM NaCl, dH 6.5) under nitrogen atmosphere. Fab' fragments appearing in the void volume were used immediately for covalent at tachment to freshly prepared MPB-PE liposomes. Comple tion of the reduction process was checked by HPLC (TSK-3000 SW column, length 60 cm, LKB, Bromma, Sweden), after adding an excess of NEM to an aliquot of the resulting protein solution. The HPLC equipment con sisted of the following components: a solvent delivery system (Waters, model 6000A), a manual injector (Rheodyne, model 7125), a U V /V IS variable wavelength detec tor (Waters, model 450) operating at 280 nm. After injec tion of 25 /xl of the standards or the sample, the column was eluted isocratically with phosphate buffer (0.1 M, 0.1 M KC1, pH 7.0) using a flow of 1 m l/m in. The following standards were used for calibration: bovine serum albumin and its dimer ovalbumin, carbonic anhydrase, lactalbumin and insulin.
Preparation of (immuno)liposomes
jV-(4-( /?-Maleimidophenyl)butyryl)phosphatidylethanolamine (MPB-PE) was synthesized, purified and analyzed as described before [22, 23] . MPB-PE was incorporated into the liposomal bilayer to couple Fab' fragments cova lently to liposomes. Lipid mixtures composed of PC /PG /C hol/M PB -PE of varying molar ratios were dis solved in chloroform and dried to a thin film by using a rotary evaporator at 40° C under reduced pressure. Ra dioactive (immuno)liposomes were prepared by addition of [3H]cholesteryloIeoylether to the chloroform mixture. Af ter evacuation for at least 1 h the lipid film was hydrated in Hepes buffer (20 mM Hepes, 135 mM NaCl, pH 7.4) or alternatively in CF solution (100 mM CF, 10 mM Tris-HCl, pH 7.4). The resulting multilamellar liposome dispersion was sequentially extruded through 0.6 /xm and 0.2 /xm polycarbonate membranes (Uni-pore, Bio-Rad) under ni trogen pressure [24] . Vesicles formed by this procedure had on the average 1.5 bilayers as reported by Jousma et al. [25] . After extrusion, the outside buffer was exchanged by applying ultracentrifugation (80 000 X g, 45 min). The pellet was redispersed in acetate buffer (100 mM NaAc, 88 mM NaCl, pH 6.5) followed by flushing with N2 (g). Routinely (unless otherwise stated), freshly prepared lipo somes (8 -1 2 /xmol T L /m l) were incubated with freshly prepared Fab' fragments (0.3-0.4 m g/m l) in nitrogen atmosphere. Samples were taken to determine the Fab' and the lipid concentration during incubation. The coupling reaction was carried out at 4° C under constant rotation overnight. Finally, the immunoliposomes were separated from unconjugated Fab' fragments by ultracentrifugation at 80 000 X g during 45 min. The pellet was resuspended and washed twice with Hepes buffer. MPB-PE liposomes, not incubated with Fab' fragments and further referred to as unconjugated liposomes, were exposed to the same treat ment. Liposome dispersions were stored at 4°C under nitrogen atmosphere.
Liposome characterization
Lipid phosphate was determined by the colorimetric method of Fiske and SubbaRow [26] . Protein was deter mined by the method of Wessel [27] , with bovine serum albumin (BSA) as standard. The amount of monoclonal antibody coupled to the liposomes was expressed as ¡xg of protein per /xmol of total lipid (TL). At the concentration used (100 mM), CF fluorescence is fully quenched. Leaked CF will attain in the medium a concentration which allows the dye to fluoresce. Before and after destruction of the liposomes by addition of 0.5% Triton X-100 and subse quent heating (70° C, 30 min), CF fluorescence was as sayed at 518 nm emission wavelength and 489 nm excita tion wavelength in a Kontron Instruments spectrofluorimeter, Model SFM 25 (Watford/Herts, UK) [28] . Ra dioactivity was measured in Hionic Fluor as scintillation mixture in a Tri-Carb 1500 liquid scintillation counter (Packard Instruments, Downers Grove, IL, USA). Mean particle size was determined by dynamic light scattering (DLS) with a Malvern 4700 system using a 25 mW He-Ne laser and the automeasure vsn 3.2 soft-ware (Malvern, UK). For viscosity and refractive index the values of pure water were used. As a measure of the particle size distribu tion of the dispersion the system reports a polydispersity index. This index ranges from 0.0 for an entirely monodisperse up to 1.0 for a completely poly disperse disper sion. Zeta-potentials were measured in a PC-3 cell with a Malvern zeta-sizer IIC (Malvern).
Release kinetics in buffer and serum
The release characteristics of CF-containing MPB-PE liposomes and OV-TL3 immunoliposomes were deter mined after incubation for 5, 24 and 48 h in Hepes buffer (20 mM Hepes, 135 mM NaCl, pH 7.4) and fetal calf serum (FCS) (Gibco). (Immuno)liposomes at a concentra tion of approx. 10 /xmol T L /m l were mixed (1:1) with buffer or serum. The incubations were performed in dupli cate at 37° C under continuous agitation. CF release was assayed as described above. 
Tumor model

Cell binding assay
Cell binding assays were performed on in vitro growing OVCAR-4 cells or on cells present in ascites collected from OVCAR-4 tumor bearing athymic nude mice. Cul tured monolayers of OVCAR-4 cells were treated with trypsin/EDTA (0.25%/0.02%). A suspension of cells in PBS was mixed with an equal volume of CF containing (immuno)liposomes. Incubations were performed in dupli cate or triplicate under continuous agitation. Unbound (immuno)liposomes were separated from the cells by cen trifugation (800 X g, 5 min). The cell pellet was washed twice with PBS and resuspended in 0.5 ml PBS containing 0.5% Triton X-100 (v /v ), followed by heating for 30 min at 70° C to lyse cell-bound (immuno)liposomes. After cen trifugation at 1500 X g during 10 min, supernatants were analyzed for CF as described above. In case of radioactive (immuno)liposomes the washed cell pellet was transferred into a vial and digested by the addition of 1 ml Soluene-350 at 40° C for one night, yielding a clear solution. Radioac tivity was measured in Hionic Fluor as described above.
Electron microscopy
OV-TL3 immunoliposomes (coupling ratio: 6 fxg
Fab'/yu-mol TL) and MPB-PE liposomes were adminis tered i.p. in OVCAR-4 tumor-bearing NMRI athymic nude mice. Solid i.p. tumors (0.5-0.6 g) and ascites (1 -2 ml) were present at the time of injection. Each mouse received a liposome dose of 8 /xmol TL in 0.5 ml of Hepes buffer pH 7.4. After 5 h, the mice were killed and the ascites was collected and washed twice with PBS by centrifugation (800 X g, 5 min). The final cell pellet was double-fixed in glutaraldehyde-tricomplex fixative (glutaraldehydepotassium ferrocyanide-calcium chloride-cacodylate buffer), followed by a postfixation in an osmium-tricomplex solution (osmic acid-potassium ferrocyanide-calcium chloride-cacodylate buffer) [32] . Dehydration was per formed in an ascending series of ethanols and the cells were embedded in Epon 812. Diamond-cut ultrathin sec tions with a Reichert OM U3 ultramicrotome were exam ined either unstained or uranyl acetate contrasted in a Philips EM 300/301 electron microscope.
Results and discussion
Factors which should be taken into account when con sidering the preparation of immunoliposomes are: (1) a sufficient quantity of antibodies must be bound to the liposomal surface in a reproducible way; (2) the integrity of the liposomes should be preserved during the coupling process; (3) the liposome-antibody complex must be suffi ciently stable on storage and after administration in vivo; (4) the homing capacity of the antibodies should be pre served after binding to the liposomes.
Preparation and characterization of antibody (frag ment) preparations
The mouse monoclonal antibody OV-TL3 is a promis ing candidate for immunotargeting of ovarian cancer. It is directed against cell surface antigenic determinants present on more than 90% of human ovarian carcinomas of differ ent histological types and shows very little affinity for nonovarian carcinoma cells [33] . The monoclonal antibody RIV1000, in the present studies used as an irrelevant monoclonal antibody, is directed against human lympho cytes [34] .
The purity of the purified antibody preparations (IgG and F(ab')2) was confirmed by SDS-PAGE. The p i values of the intact antibodies as well as the F(ab')2 fragments, produced by pepsin digestion of the IgG molecules, were determined by IEF. For the OV-TL3 antibody the p I values of the bands ranged from 6.8 to 7.1 for intact IgG and from 8.2 to 8.7 for F(ab')2 fragments. The p i values of the RIV1000 antibody ranged from 5.8 to 6.6 for intact IgG and 5.5 to 8.0 for F(ab')2 fragments. This indicates that the F(ab')2 and therefore also the Fab' fragments of the OV-TL3 antibody were positively charged at neutral pH.
The immunoreactivity of purified IgG and F(ab')2 frag ments of OV-TL3 and RIV1000 to OVCAR-4 cells was determined using flow cytometry ( Fig. 1 illustrate the suitability of the RIV1000 antibody to be used as an irrelevant antibody in our studies concerning targeting of immunoliposomes to ovarian carcinoma. OV-TL3 did not react with nonrelevant target cells (the murine squamous cell carcinoma 5D04 [35] and human bladder carcinoma T24) in flow cytometric studies (results not shown).
) The data indicate that at the protein concentrations tested the reactivity of F(ab')o-0V-TL3 was maintained. In addition, the results
For immunospecific targeting Fab' fragments of OV-TL3 were covalently linked to MPB-PE liposomes (see below). The Fab' fragments were generated from F(ab')2 fragments by dithiothreitol (DTT) incubation. The experi mental conditions used (incubation for 90 min at pH 5.5 at room temperature) were taken from Martin and Kung [36] . Addition of excess /V-ethylmaleimide to the reaction mix ture was used to stop the reduction process. The DTT concentration was assessed for a complete reduction of F(ab')2 dimers to Fab' monomers. The HPLC profiles presented in Fig. 2 show that this is achieved at a DDT concentration of 20 mM. The same result was obtained for RIV1000 F(ab')2 (results not shown). Therefore, it was decided to use routinely 20 mM DDT for the preparation of Fab' fragments.
Choice of preparation method
We prepared routinely multilamellar liposomes (MLV) consisting of PC, PG, Choi, and the sulfhydryl-reactive phospholipid derivative MPB-PE (2.5 mol%). Bangham and co-workers reported on the preparation of MLV for the first time [37] , and their method has proven to be very popular. MLV are suitable for the encapsulation of a variety of substances and can be made with a wide variety of lipid compositions [38] , A difficulty with Bangham's method is the lack of control over the vesicle size distribu tion. Therefore, the liposomes were extruded through poly carbonate membranes with pore sizes of 0.6 and 0.2 /xm to overcome this problem. Interestingly, instead of having a multilamellar nature, such extruded liposomes have been reported to be uni-or oligolamellar (one to three bilayers) [25] .
Many different techniques for the coupling of antibod ies to liposomes have been described [1, 40] . We have used one of the most popular conjugation methods involving the use of the bifunctional agent MPB-PE [22] (Fig. 3 ). This technique was selected from a number of options for the following reasons: (1) mild conditions are maintained dur ing coupling, avoiding a decrease in the immunoactivity of the coupled antibody fragment; (2) Fab' fragments are covalently linked to the MPB-PE anchor present in the outer lipid bilayers of preformed liposomes. This method presumably results in an adequate orientation of the Fab' fragments on the liposomes: the antigen binding sites are outward directed and fully accessible to antigen binding. Moreover, the thio-ether bridge has proven to be stable in vivo, contrary to the alternatively used disulfide bridge; great importance for in vivo use of Fab' vesicles. In this way the Fc receptor of macrophages is not activated and elimination of the liposome, by the mononuclear phago-cyte system (MPS), might be reduced and slowed down [14] .
Optimization of the coupling of Fab' to MLV
Coupling of a (sulfhydryl-group exposing) protein to liposomes containing maleimide residues merely requires mixing of the liposomes and the protein, which has been reduced and separated from DTT. The coupling efficiency was investigated under various reaction conditions. The liposomes used were composed of PC, PG, Choi and 2.5 mol% MPB-PE (38.5:4:16:1.5 molar ratio).
The stability of the maleimide group of MPB-PE is known to be sensitive to pH [41] . Especially at pH values greater than 7.0 rapid degradation of the maleimide residue has been reported [42] . A pH of 6.5 was recommended for use in the coupling reaction [22, 43] . This pH was also used in our studies. However, as the marker carboxy fluorescein (CF), occasionally entrapped to monitor cell binding, be comes protonized and loses its charge at low pH [28, 44] , the preformed MPB-PE liposomes were prepared and stored at a pH of 7.4. The MPB-PE vesicles were used as freshly as possible; the maleimide function was exposed to pH 7.4 for maximally 8 h. Nevertheless, it was investigated whether the relatively short exposure to pH 7.4 may cause a significant loss of maleimide reactivity which might then be expected to result in a drop in coupling efficiency. Liposomes containing 2.5 mol% MPB-PE were prepared at pH 5 .5 as well as at pH 7.4 under standard experimental conditions (described in Materials and methods). Fab' fragments were coupled to the freshly prepared vesicles at pH 6.5. The protein to lipid ratios (coupling ratios) were similar and amounted to 9.5 /xg Fab'//xm ol TL and 10.7 fig Fab'//Amol TL for the 'pH 5.5 dispersion' and the 'pH 7.4 dispersion', respectively. These results indicate that we could use a pH of 7.4 during our standard preparation procedure prior to Fab' coupling. Results of Peeters et al. [45] and Loughrey et al. [42] indicate that the exposure to pH 7.4 for prolonged periods (> 8 h) results in a decrease of coupling efficiency. Therefore, in line with their results, the time span between the start and the end of exposure to this pH never exceeded 8 h.
It has been reported that an incubation time of 6 h is sufficient for protein conjugation to MPB-PE liposomes [43] . For reasons of practical convenience it was examined whether the coupling reaction could proceed overnight Table 1 presents results of the effect of incubation time/temperature on the coupling ratio of the reaction product. It was found that under typical reaction conditions as described in Materials and methods much more of the added OV-TL3 Fab' was coupled to liposomes overnight (14 h) than in the shorter incubation time peri ods. Bredehorst et al. [46] studied the time course of the coupling reaction over a period of 20 h. They observed that the coupling ratio reached a plateau value in about 5 h after start of incubation. Based on their and our results, it Antigen combining sites Table 2 shows the increase in the amount of coupled Fab' with an increasing mol fraction of MPB-PE. No nonspecific binding of Fab' to the liposomes was observed ( Table 2 ). Coupling efficiencies of up to 30 to 50% were readily achieved under the standard experimental conditions employed (as described in Materials and methods). The efficient coupling of pro tein to liposomes containing lower levels of MPB-PE is of particular importance as higher concentrations of this an chor molecule (> 2.5 moI%) dramatically affected lipo some stability [46] . For this reason we have chosen, as other investigators [22, 47] , 2.5 mol% MPB-PE (on a total lipid basis) as the standard maleimide content of the liposomes.
MPB-PE liposome Fab'-immunoliposome
The amount of coupled Fab' molecules to 2.5 mol% MPB-PE liposomes could be varied by changing the initial Fab' concentration or by changing the liposome concentra tion in the coupling reaction mixture (Fig. 4) . The relation ship between coupling ratio and Fab' concentration ap peared to be linear over the concentration range from 0.1 to 0.7 m g/m l of Fab' fragments. In addition, the coupling ratio appears to be inversely correlated with the total liposome concentration in the reaction mixture. Interest ingly, by increasing the Fab' concentration or decreasing the lipid concentration in the incubation mixture the cou pling efficiency increased and leveled off at 30%. Flexibil ity of the method for adjusting desired coupling ratios is illustrated. Routinely, we used approx. 0.3-0.4 fig Fab' /m l and approx. 8-12 fimol T L /m l for the preparation of OV-TL3 (and RIV1000) immunoliposomes.
Characterization
A proper physicochemical characterization of immuno liposomes is not always included in the literature reports. The physicochemical properties of immunoliposomes will strongly influence their disposition in vivo and their behav ior in vitro [48, 49] . Therefore, it is important to prepare immunoliposomes well characterized in terms of Fab' cou pling ratio, particle size and surface charge, with accept- able long term stability and preservation of immunoreactivity.
Characteristics of standard preparations of the OV-TL3 and the RIV1000 immunoliposomes are presented in Table  3 . The protein to lipid (coupling ratio) varied only slightly between the different immunoliposome preparations. It was estimated that at a coupling ratio of 10 ¡jlg F ab'//m ol TL approx. 240 Fab' molecules were present on one liposome particle. By covalent attachment of OV-TL3 Fab' fragments to the MPB-PE liposomes the negative zetapotential was altered from -24 ± 2 mV to -17 + 1 mV for the MPB-PE lioosomes and the OV-TL3 immunnlinr»- tion. Under the experimental conditions used in this study (see legend Table 3 ) these effects were of minor impor tance. liposomes).
Stability
The following aspects concerning the stability of the OV-TL3 immunoliposomes were examined: (1) the occur rence of changes in vesicle size; (2) retention of entrapped contents; (3) influence of serum on the retention of en trapped contents; (4) preservation of immunoreactivity on storage. The liposomes contained entrapped CF as a fluo rescent marker for monitoring liposomal stability.
The mean particle size of immunoliposomes with differ ent coupling ratios (up to 21 fig Fab'//xm ol TL) changed slightly during storage of the dispersion at 4° C for a period of 4 weeks (Fig. 5 ). No change in polydispersity index was found for the MPB-PE liposomes (pd 0.15) during 4 weeks of storage and a moderate increase in polydispersity from 0.14 to 0.22 was measured for OV-TL3 immunoliposomes with a coupling ratio of 21 /xg Fab'//xmol TL (results not shown). A slight increase in mean particle size was observed with increasing number of Fab' fragments coupled per liposome (Fig. 5 ). The loss of Table 3 Characterization of standard preparations of MPB-PE liposomes, OV-TL3 immunoliposomes and RIV1000 immunoliposomes negatively charged molecules in the bilayers contributes to prevention of aggregation (and/ or fusion). The zeta-poten tial of the immunoliposomes and the Fab' coupling ratio appear to be linearly related: the higher the coupling ratio, the lower the negative zeta-potential (Fig. 6 ). The decrease in negative zeta-potential as a function of coupling ratio is most likely related to our observation that the OV-TL3 Fab' fragments are positively charged at neutral pH (see above). The neutralizing capacity of increasing amounts of coupled Fab' leading to reduced electrostatic repulsive forces may induce a tendency of immunoliposomes to aggregate. Interestingly, literature reports on increases in size and polydispersity are based on studies employing immunoliposomes with coupling ratios by far exceeding those used in the present study [36, 46] .
CF over a 3-week period storage was minimal (<5%; results not shown). The permeability of liposomes was also studied in the presence of fetal calf serum. The MPB-PE liposomes and the OV-TL3 immunoliposomes showed only minor CF leakage during incubation in 50% serum at 37° C for 2 days (results not shown). With respect to preservation of immunoreactivity, the capacity of the im munoliposomes to bind to in vitro cultured ovarian carci noma cells was maintained after storage for 1 month at 4° C (results not shown). Various coupling procedures have been reported with detailed analysis of coupling efficiency, preservation of antibody activity, and stability of the cross-link between antibody and liposome [3] . However, very few studies have addressed the stability of immunoliposomes on stor age. Bredehorst et al. [46] observed that covalent coupling of Fab' fragments to preformed MPB-PE liposomes can have major effects on liposomal integrity, size, and poly dispersity. Such effects were not observed in this study. In general, inclusion of sufficient amounts of cholesterol is important to obtain liposomes with low permeability char acteristics [50] . In addition, it is likely that the presence of
Binding to ovarian carcinoma cells
As specific association of immunoliposomes with their target cells is a necessary requirement for target-specific drug delivery, we evaluated the binding of OV-TL3 im munoliposomes containing CF as an aqueous marker to the OVCAR-4 human ovarian tumor cell line. Measurements of cell binding after incubation with cells at 37° C may include both binding and uptake; therefore, cell binding was studied at 4° C since endocytosis does not occur at this temperature [51, 52] . To show specificity of the OV-TL3 immunoliposomes towards the OVCAR-4 cells, negative control binding experiments were performed. OV-TL3 im munoliposomes were incubated with nonovarian carci noma cells, the murine gastric squamous cell carcinoma 5D04 was used [35] . In addition, the degree of cell binding towards OVCAR-4 was determined for nonspe cific immunoliposomes (bearing the irrelevant antibody RIV1000), MPB-PE liposomes, liposomes without incor porated MPB-PE and liposomes without incorporated MPB-PE preincubated with OV-TL3 Fab' fragments. All these negative control incubations resulted in very low binding values. In Figs. 7 -9 only the control data obtained with MPB-PE liposomes and RIV1000 immunoliposomes are presented. Fig. 7 shows the degree of (immuno)liposome binding to OVCAR-4 cells after 1.5 h of incubation at 4° C. As the concentration of added OV-TL3 immunoliposomes was increased (at a constant cell concentration), the absolute amount of bound immunoliposomes increased (A), while the fraction bound decreased (B). The opposite was the case when the tumor cell concentration was increased (at a constant liposome concentration) ( Fig. 8) . It was estimated that approx. 3.5 • 104 liposomes were bound per cell at a binding ratio of 70 nmol T L /1 0 fi cells (Fig. 8 ). Fig. 9 shows the dependency of the degree of cell binding on the incubation time. Under the chosen conditions, cell binding was maximal within 0.5 h after start of the incubation, demonstrating that an incubation time of 1.5 h was suffi cient.
All in vitro incubations presented so far were performed at 4° C. In view of the in vivo situation, it was of interest C /3 to compare the binding capacity of the OV-TL3 i posomes at 4° C and at 37 C. As we observed cellted leakage of liposomal CF during incubation at 37 Specific binding was additionally demonstrated on in vivo propagated OVCAR-4 cells harvested in ascites form. As these cells grew in large cell clusters it was not possible to determine the cell concentration. Therefore, no comparison can be made with the in vitro propagated binding percentages amounted to 34 ± 1% (mean ± S.D. of three incubations) for the OV-TL3 immunoliposomes (6 fjug Fab'//xmol TL) and 1.0% (mean of two incubations, individual values deviated 0.1% from the mean) for MPB-PE liposomes.
Finally, Fig. 11 shows electron micrographs of in vivo growing OVCAR-4 cells 5 h after i.p. administration of OVCAR-4 cells with regard to cell binding capacity. The (immuno)liposomes. These EM micrographs revealed im performed by mixing (1:1) freshly vested ascites with CF-containing (immuno)liposomes (16 fjbmol TL/m l). Under the experimental conditions cell munoliposomes associated with exposed tumor cells con firming the ability of OV-TL3 immunoliposomes to bind to ovarian carcinoma cells in vivo. Negative iments with MPB-PE liposomes did not reveal any interac tion upon inspection.
Concluding remarks
Immunoliposomes bearing antibodies which are di rected against cell surface antigens such as those associ ated with transformed cells, may have therapeutic poten tial. However, at the present time, such targeted liposomal systems have mainly been used for in vitro applications such as diagnostic assays [57] . In order to exploit the full potential of antibody-targeted carrier systems a versatile and reliable methodology for coupling is required. This report addresses an established method for the binding of Fab' fragments of OV-TL3 (monoclonal anti-ovarian carci noma IgG) to anchor MPB-PE. The amount of protein bound to the vesicles can be controlled within limits by varying the protein an d /o r lipid concentration in the coupling reaction mixture. The product was stable over at least 3 terms of leakage of encapsulated CF, particle size and antigen binding capacity. OV-TL3 immunoliposomes were shown to bind specifically to OVCAR-4 target cells in vitro and in vivo. The subsequent events which follow cell binding are currently under investigation since liposome in the encapsulated drug into the target cell. Uptake of im munoliposomes by target cells has been shown to occur via receptor-mediated endocytosis, which varies consider ably from one surface receptor to another and from one cell type to another [60] . Recent results from our labora tory did not provide evidence that internalization of OV-TL3 immunoliposomes by the OVCAR-4 tumor cells is of quantitative importance [58] . One future objective is to use other homing ligands directed to surface receptors known to be internalized by cells at a high rate, and conjugate them with target cell specific small-sized immunolipo somes. Several other options for drug entry into the target cell which do not depend on internalization of the carrier are also under investigation. One option is that the encap sulated drug simply leaks out of the cell-bound immunoli posomes in the close proximity of the tumor cell. A sufficiently high concentration gradient over the cell mem brane may result in considerable cellular drug uptake. Special attention is additionally focused on the use of 'special function' immunoliposomes from which release of entrapped agents is triggered by environmental manipula tions (e.g., by a slight change of the temperature or pH) after their binding to the tumor cells [3, 4] ,
